Independent Financial Group’s Virtus Biotech ETF BBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$720K Buy
7,476
+128
+2% +$11.1K 0.01% 824
2026
Q1
$610K Buy
7,348
+185
+3% +$15.2K 0.01% 828
2025
Q4
$572K Buy
7,163
+35
+0.5% +$2.66K 0.01% 841
2025
Q3
$499K Buy
7,128
+20
+0.3% +$1.31K 0.01% 858
2025
Q2
$414K Buy
7,108
+335
+5% +$18.9K 0.01% 864
2025
Q1
$397K Buy
6,773
+150
+2% +$9.2K 0.01% 805
2024
Q4
$398K Buy
6,623
+1,040
+19% +$65.8K 0.01% 788
2024
Q3
$351K Buy
5,583
+58
+1% +$3.61K 0.01% 811
2024
Q2
$325K Buy
5,525
+1,165
+27% +$64.9K 0.01% 790
2024
Q1
$247K Buy
+4,360
New +$254K 0.01% 873

Other funds holding BBP

Independent Financial Group's BBP Position: Q2 2026 in Review

Independent Financial Group increased its Virtus Biotech ETF (BBP) stake by 1.7% in Q2 2026, buying an estimated $11.1K and bringing the position to 7,476 shares worth $720K. The position accounts for 0.01% of the portfolio, ranked #824.

Independent Financial Group first reported a position in BBP in Q1 2024 and has held it in 10 quarters since. 26 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

  • Independent Financial Group held 7,476 shares of Virtus Biotech ETF worth $720K as of Q2 2026.
  • Independent Financial Group bought 128 Virtus Biotech ETF shares in Q2 2026, an estimated $11.1K.
  • Virtus Biotech ETF made up 0.01% of Independent Financial Group's portfolio in Q2 2026, its #824 holding.
  • Independent Financial Group first reported a position in Virtus Biotech ETF in Q1 2024 and has held it in 10 quarters since.
  • 26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.